Triad Hydrophilic Wound Dresssing (1964, 2.5 oz); Triad Hydrophilic Wound Dressing (1967, 6 oz)
Coloplast Corp. · Decision date Oct 26, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-26 for K260285, submitted by Coloplast Corp. of Minneapolis, Minnesota, and received on 01/29/2026. The device is listed as Triad Hydrophilic Wound Dresssing (1964, 2.5 oz) and Triad Hydrophilic Wound Dressing (1967, 6 oz), with product code FRO and classification name Dressing, Wound, Drug22. In 510(k) terms, SESE means the submission was cleared as substantially equivalent; it is not a PMA approval.
The review panel is recorded as General & Plastic Surgery, while the specialty field in the structured record is listed as Unknown. The source material does not identify a predicate device, describe the technological characteristics compared, or state the basis for the equivalence finding, and no decision statement text is included. The two listed product sizes are the only device variants named; any further components or changed items are not described in the available record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Unknown
- Decision date
- Oct 26, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260285
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Coloplast Corp.
- Product code
- FRO
- Decision code
- SESE
- Decision date
- Oct 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Dressing, Wound, Drug.
- Applicant
- Coloplast Corp.
- Product code
- FRO
- FDA device class
- U
FDA decision timeline
K260285 received
Application receipt date recorded by FDA.
K260285 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FRO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ACTO GmbH | 510(k) clearance | Sep 22, 2026 | FDA | |
| Magic Science Supply, LLC | 510(k) clearance | Sep 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Coloplast Corp.
- Headquarters
- Not reported
- Brand website
- coloplast.com
- FDA applicant address
- Minneapolis, MN
Sources and methodology
- Original FDA record: K260285
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
